Amalgamated Bank Trims Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Amalgamated Bank lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 76,006 shares of the medical equipment provider’s stock after selling 155 shares during the period. Amalgamated Bank’s holdings in Intuitive Surgical were worth $33,811,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Ridgewood Investments LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth $26,000. Creekmur Asset Management LLC raised its holdings in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the period. LGT Financial Advisors LLC raised its holdings in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares during the period. Delos Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the period. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The disclosure for this sale can be found here. In the last three months, insiders sold 53,120 shares of company stock valued at $25,528,753. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Piper Sandler upped their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Truist Financial lifted their target price on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a report on Tuesday, July 16th. The Goldman Sachs Group initiated coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Finally, BTIG Research lifted their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $446.45.

Intuitive Surgical Stock Down 1.6 %

Shares of ISRG stock opened at $483.32 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.18. The stock has a market capitalization of $171.43 billion, a PE ratio of 87.24, a P/E/G ratio of 5.41 and a beta of 1.39. The firm has a 50 day moving average of $465.50 and a two-hundred day moving average of $423.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the previous year, the company earned $1.18 EPS. Analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.